The novel CFAbd-Score.kid© reveals a significant decline of abdominal symptoms in children with Cystic fibrosis aged 6 through 11 years on Elexacaftor/Tezacaftor/Ivacaftor-first results

DSpace Repositorium (Manakin basiert)

The novel CFAbd-Score.kid© reveals a significant decline of abdominal symptoms in children with Cystic fibrosis aged 6 through 11 years on Elexacaftor/Tezacaftor/Ivacaftor-first results

Autor(en): Mainz, Jochen G.; Sadrieh, Pauline; Bechinger, Lilith; Duckstein, Franziska; Barucha, Anton; Polte, Louise; Naehrlich, Lutz; Eickmeier, Olaf; van Dullemen, Suzanne; Graepler-Mainka, Ute; Zagoya, Carlos
Tübinger Autor(en):
Graepler-Mainka, Ute
Erschienen in: Journal of Cystic Fibrosis (2025), Bd. 24, H. 5, S. 894-902
Verlagsangabe: Amsterdam : Elsevier
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1016/j.jcf.2025.09.003
ISSN: 1569-1993
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: